FDA Import Refusal AEK-6367885-5/21/1 — Astrazeneca Latin America, Inc
The FDA refused shipment AEK-6367885-5/21/1 from Astrazeneca Latin America, Inc (United States) on Oct 1, 2019. The refused product falls under Drugs and Biologics — SAXAGLIPTIN HYDROCHLORIDE (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- Oct 1, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PAY67 SAXAGLIPTIN HYDROCHLORIDE (ANTI-DIABETIC)
- Charges
- 75